The mitochondrial-targeted antioxidant MitoQ ameliorates metabolic syndrome features in obesogenic diet-fed rats better than Apocynin or Allopurinol

References

• Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448–1454.
   PubMed Web of Science ®Google Scholar
• Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007;86:285–300.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Stenvinkel P, Martin SL, Jani A, Sanchez-Lozada LG, Hill JO, Lanaspa MA. Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity (Silver Spring) 2013;21: 659–664.
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009;119:573–581.
   PubMed Web of Science ®Google Scholar
• Ando K, Fujita T. Metabolic syndrome and oxidative stress. Free Radic Biol Med 2009;47:213–218.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84.
   PubMed Web of Science ®Google Scholar
• Abete I, Goyenechea E, Zulet MA, Martinez JA. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 2011;21:B1–B15.
   PubMed Web of Science ®Google Scholar
• Mao G, Kraus GA, Kim I, Spurlock ME, Bailey TB, Zhang Q, Beitz DC. A mitochondria-targeted vitamin E derivative decreases hepatic oxidative stress and inhibits fat deposition in mice. J Nutr 2010;140:1425–1431.
   PubMed Web of Science ®Google Scholar
• Smith RA, Hartley RC, Cocheme HM, Murphy MP. Mitochondrial pharmacology. Trends Pharmacol Sci 2012; 33:341–352.
   PubMed Web of Science ®Google Scholar
• Smith RA, Hartley RC, Murphy MP. Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal 2011;15:3021–3038.
   PubMed Web of Science ®Google Scholar
• Tauskela JS. MitoQ–a mitochondria-targeted antioxidant. IDrugs 2007;10:399–412.
   PubMed Web of Science ®Google Scholar
• Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapies. Discov Med 2011;11:106–114.
   PubMed Web of Science ®Google Scholar
• Lim S, Rashid MA, Jang M, Kim Y, Won H, Lee J, et al. Mitochondria-targeted antioxidants protect pancreatic beta-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity. Cell Physiol Biochem 2011;28:873–886.
   PubMedGoogle Scholar
• Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 2010;30:1019–1026.
   PubMed Web of Science ®Google Scholar
• Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010;1201:96–103.
   PubMed Web of Science ®Google Scholar
• Stefanska J, Pawliczak R. Apocynin: molecular aptitudes. Mediators Inflamm 2008;2008:106507.
   PubMed Web of Science ®Google Scholar
• Guichard C, Moreau R, Pessayre D, Epperson TK, Krause KH. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? Biochem Soc Trans 2008;36:920–929.
   PubMed Web of Science ®Google Scholar
• Wind S, Beuerlein K, Eucker T, Muller H, Scheurer P, Armitage ME, et al. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol 2010; 161:885–898.
   PubMed Web of Science ®Google Scholar
• Meng R, Zhu DL, Bi Y, Yang DH, Wang YP. Apocynin improves insulin resistance through suppressing inflammation in high-fat diet-induced obese mice. Mediators Inflamm 2010; 2010:858735.
   PubMed Web of Science ®Google Scholar
• Castro MC, Francini F, Schinella G, Caldiz CI, Zubiria MG, Gagliardino JJ, Massa ML. Apocynin administration prevents the changes induced by a fructose-rich diet on rat liver metabolism and the antioxidant system. Clin Sci (Lond) 2012; 123:681–692.
   PubMed Web of Science ®Google Scholar
• Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 2002;33: 774–797.
   PubMed Web of Science ®Google Scholar
• Nishino T, Nakanishi S, Okamoto K, Mizushima J, Hori H, Iwasaki T, et al. Conversion of xanthine dehydrogenase into oxidase and its role in reperfusion injury. Biochem Soc Trans 1997;25:783–786.
   PubMedGoogle Scholar
• Vida C, Corpas I, De la Fuente M, Gonzalez EM. Age-related changes in xanthine oxidase activity and lipid peroxidation, as well as in the correlation between both parameters, in plasma and several organs from female mice. J Physiol Biochem 2011;67:551–558.
   PubMedGoogle Scholar
• Peglow S, Toledo AH, Anaya-Prado R, Lopez-Neblina F, Toledo-Pereyra LH. Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion. J Hepatobiliary Pancreat Sci 2011;18:137–146.
   PubMed Web of Science ®Google Scholar
• Suzuki I, Yamauchi T, Onuma M, Nozaki S. Allopurinol, an inhibitor of uric acid synthesis–can it be used for the treatment of metabolic syndrome and related disorders? Drugs Today (Barc) 2009;45:363–378.
   PubMed Web of Science ®Google Scholar
• Bravard A, Bonnard C, Durand A, Chauvin MA, Favier R, Vidal H, Rieusset J. Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Am J Physiol Endocrinol Metab 2011;300:E581–591.
   Google Scholar
• Mercer JR, Yu E, Figg N, Cheng KK, Prime TA, Griffin JL, et al. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/−/ApoE−/− mice. Free Radic Biol Med 2012;52:841–849.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cuenca S, Cocheme HM, Logan A, Abakumova I, Prime TA, Rose C, et al. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med 2010;48:161–172.
   PubMed Web of Science ®Google Scholar
• Chacko BK, Srivastava A, Johnson MS, Benavides GA, Chang MJ, Ye Y, et al. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology 2011;54:153–163.
   PubMed Web of Science ®Google Scholar
• Meng R, Zhu DL, Bi Y, Yang DH, Wang YP. Anti-oxidative effect of apocynin on insulin resistance in high-fat diet mice. Ann Clin Lab Sci 2011;41:236–243.
   PubMed Web of Science ®Google Scholar
• Kono H, Rusyn I, Bradford BU, Connor HD, Mason RP, Thurman RG. Allopurinol prevents early alcohol-induced liver injury in rats. J Pharmacol Exp Ther 2000;293:296–303.
   PubMed Web of Science ®Google Scholar
• Aoun M, Fouret G, Michel F, Bonafos B, Ramos J, Cristol JP, et al. Dietary fatty acids modulate liver mitochondrial cardiolipin content and its fatty acid composition in rats with non alcoholic fatty liver disease. J Bioenerg Biomembr 2012; 44:439–452.
   PubMedGoogle Scholar
• Pu P, Gao DM, Mohamed S, Chen J, Zhang J, Zhou XY, et al. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Arch Biochem Biophys 2012;518:61–70.
   PubMed Web of Science ®Google Scholar
• Aoun M, Michel F, Fouret G, Casas F, Jullien M, Wrutniak-Cabello C, et al. A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway. Br J Nutr 2010;104:1760–1770.
   PubMedGoogle Scholar
• Michel F, Bonnefont-Rousselot D, Mas E, Drai J, Therond P.[Biomarkers of lipid peroxidation: analytical aspects].Ann Biol Clin (Paris) 2008;66:605–620.
   PubMed Web of Science ®Google Scholar
• Faure P, Lafond J. Measurement of plasma sulfhydryl and carbonyl groups as a possible indicator of protein oxidation. In: Favier A, Cadet J, Kalyanaraman B, Fontecave M, Pierre J, (eds.). Analysis of Free Radicals in Biological Systems. Basel (Switzerland): Birkhauser Verlag 1995. pp. 237–248.
   Google Scholar
• Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161:2524–2532.
   PubMed Web of Science ®Google Scholar
• Munch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, et al. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997; 35:669–677.
   PubMedGoogle Scholar
• Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980;106:207–212.
   PubMed Web of Science ®Google Scholar
• Beers R, Sizer I. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952;195:133–140.
   PubMed Web of Science ®Google Scholar
• Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114–121.
   PubMed Web of Science ®Google Scholar
• Marklund S. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J Biol Chem 1976; 251:7504–7507.
   PubMed Web of Science ®Google Scholar
• Spickett CM, Wiswedel I, Siems W, Zarkovic K, Zarkovic N. Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res 2010; 44:1172–1202.
   PubMed Web of Science ®Google Scholar
• Feillet-Coudray C, Sutra T, Fouret G, Ramos J, Wrutniak-Cabello C, Cabello G, et al. Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med 2009;46:624–632.
   PubMed Web of Science ®Google Scholar
• Feillet-Coudray C, Fouret G, Bonafos B, Aoun M, Carillon J, Sutra T, et al. Xanthine oxidase is variably involved in nutritional and physio-pathologic oxidative stress situations. J Physiobiochem Metab 2013;2:1–8.
   Google Scholar
• Aoun M, Feillet-Coudray C, Fouret G, Chabi B, Crouzier D, Ferreri C, et al. Rat liver mitochondrial membrane characteristics and mitochondrial functions are more profoundly altered by dietary lipid quantity than by dietary lipid quality: effect of different nutritional lipid patterns. Br J Nutr 2011;107:647–659.
   PubMedGoogle Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Baracca A, Sgarbi G, Solaini G, Lenaz G. Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim Biophys Acta 2003;1606:137–146.
   PubMed Web of Science ®Google Scholar
• Barja G. The quantitative measurement of H2O2 generation in isolated mitochondria. J Bioenerg Biomembr 2002;34:227–233.
   PubMed Web of Science ®Google Scholar
• Srere PA. Citrate synthase. Methods enzymol 1969;13:3–11.
   Google Scholar
• Teodoro JS, Rolo AP, Duarte FV, Simoes AM, Palmeira CM. Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. Mitochondrion 2008;8:367–376.
   PubMed Web of Science ®Google Scholar
• Flamment M, Rieusset J, Vidal H, Simard G, Malthiery Y, Fromenty B, Ducluzeau PH. Regulation of hepatic mitochondrial metabolism in response to a high fat diet: a longitudinal study in rats. J Physiol Biochem 2012;68:335–344.
   PubMedGoogle Scholar
• Lottenberg AM, Afonso MD, Lavrador MS, Machado RM, Nakandakare ER. The role of dietary fatty acids in the pathology of metabolic syndrome. J Nutr Biochem 2012; 23:1027–1040.
   PubMedGoogle Scholar
• James AM, Collins Y, Logan A, Murphy MP. Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 2012;23:429–434.
   PubMed Web of Science ®Google Scholar
• Speakman JR, Mitchell SE. Caloric restriction. Mol Aspects Med 2011;32:159–221.
   PubMed Web of Science ®Google Scholar
• Das M, Gabriely I, Barzilai N. Caloric restriction, body fat and ageing in experimental models. Obes Rev 2004;5:13–19.
   PubMedGoogle Scholar
• Guillou H, Martin PG, Pineau T. Transcriptional regulation of hepatic fatty acid metabolism. Subcell Biochem 2008; 49:3–47.
   PubMedGoogle Scholar
• Dumont M, Stack C, Elipenhali C, Calingasan NY, Wille E, Beal MF. Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer’s disease. Neurosci Lett 2011;492:150–154.
   PubMedGoogle Scholar
• Trumbull KA, McAllister D, Gandelman MM, Fung WY, Lew T, Brennan L, et al. Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice. Neurobiol Dis 2012;45:137–144.
   PubMed Web of Science ®Google Scholar
• Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 2011;51:1289–1301.
   PubMed Web of Science ®Google Scholar
• Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008;51:211–217.
   PubMed Web of Science ®Google Scholar
• Riganti C, Costamagna C, Bosia A, Ghigo D. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress. Toxicol Appl Pharmacol 2006;212:179–187.
   PubMedGoogle Scholar
• Vejrazka M, Micek R, Stipek S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim Biophys Acta 2005;1722: 143–147.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Choi SK, Seo JS. Grape skin improves antioxidant capacity in rats fed a high fat diet. Nutr Res Pract 2009;3: 279–285.
   PubMed Web of Science ®Google Scholar
• Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. Faseb J 2005;19:136–138.
   PubMed Web of Science ®Google Scholar